23 May 2013
Keywords: cytochroma, selects, psoriasis, drug, candidate, canada, selected
Article | 29 September 2003
Canada's Cytochroma has selected CTA018 as a drug candidate for the treatment of mild-to-moderate psoriasis. The company hopes to file ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
22 May 2013
© 2013 thepharmaletter.com